Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Effects of the Val158Met catechol-O-methyltransferase polymorphism on cortical structure in children and adolescents.

Shaw P, Wallace GL, Addington A, Evans A, Rapoport J, Giedd JN.

Mol Psychiatry. 2009 Apr;14(4):348-9. doi: 10.1038/mp.2008.121. No abstract available.

2.
3.

Association study on catechol-O-methyltransferase (COMT) Val158Met gene polymorphism and NEO-FFI.

Aoki J, Iwahashi K, Ishigooka J, Ikeda K.

Psychiatry Res. 2011 May 15;187(1-2):312-3. doi: 10.1016/j.psychres.2010.09.015. Epub 2010 Nov 3. No abstract available.

PMID:
21051090
4.

Asymmetry of prefrontal cortex activities and catechol-O-methyltransferase Val158Met genotype in patients with panic disorder during a verbal fluency task: near-infrared spectroscopy study.

Tanii H, Nishimura Y, Inoue K, Koshimizu H, Matsumoto R, Takami T, Hara N, Nishida A, Okada M, Kaiya H, Okazaki Y.

Neurosci Lett. 2009 Mar 6;452(1):63-7. doi: 10.1016/j.neulet.2009.01.044. Epub 2009 Jan 21.

PMID:
19429001
5.

Effect of catechol-O-methyltransferase val158met genotype on attentional control.

Blasi G, Mattay VS, Bertolino A, Elvevåg B, Callicott JH, Das S, Kolachana BS, Egan MF, Goldberg TE, Weinberger DR.

J Neurosci. 2005 May 18;25(20):5038-45.

6.

Effect of functional catechol-O-methyltransferase Val158Met polymorphism on physical aggression.

Kulikova MA, Maluchenko NV, Timofeeva MA, Shlepzova VA, Schegolkova JV, Sysoeva OV, Ivanitsky AM, Tonevitsky AG.

Bull Exp Biol Med. 2008 Jan;145(1):62-4.

PMID:
19024004
7.

The association between headache and Val158Met polymorphism in the catechol-O-methyltransferase gene: the HUNT Study.

Hagen K, Pettersen E, Stovner LJ, Skorpen F, Zwart JA.

J Headache Pain. 2006 Apr;7(2):70-4. Epub 2006 Apr 26.

8.

Association between the catechol-O-methyltransferase Val158Met polymorphism and panic disorder: a replication.

Annerbrink K, Westberg L, Olsson M, Allgulander C, Andersch S, Sjödin I, Holm G, Eriksson E.

Psychiatry Res. 2010 Jun 30;178(1):196-8. doi: 10.1016/j.psychres.2009.11.022. Epub 2010 May 8.

PMID:
20457471
9.

Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.

de Lau LM, Verbaan D, Marinus J, Heutink P, van Hilten JJ.

Mov Disord. 2012 Jan;27(1):132-5. doi: 10.1002/mds.23805. Epub 2011 Nov 14.

PMID:
22083803
10.

Association between the catechol-O-methyltransferase Val158Met polymorphism and self-perceived social acceptance in adolescent girls.

Waugh CE, Dearing KF, Joormann J, Gotlib IH.

J Child Adolesc Psychopharmacol. 2009 Aug;19(4):395-401. doi: 10.1089/cap.2008.0141.

11.

Catechol-O-methyltransferase gene val158met polymorphism and depressive symptoms during early childhood.

Sheikh HI, Kryski KR, Smith HJ, Dougherty LR, Klein DN, Bufferd SJ, Singh SM, Hayden EP.

Am J Med Genet B Neuropsychiatr Genet. 2013 Apr;162B(3):245-52. doi: 10.1002/ajmg.b.32141. Epub 2013 Mar 8.

12.

Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.

Huuhka K, Anttila S, Huuhka M, Hietala J, Huhtala H, Mononen N, Lehtimäki T, Leinonen E.

Neurosci Lett. 2008 Dec 19;448(1):79-83. doi: 10.1016/j.neulet.2008.10.015. Epub 2008 Oct 9.

PMID:
18929622
13.

[No association between catechol-O-methyltransferase val158met polymorphism and alexithymia].

Hermes S, Hennig J, Stingl M, Leichsenring F, Leweke F.

Z Psychosom Med Psychother. 2011;57(1):51-61. German.

PMID:
21432838
14.

The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults.

Taylor WD, Züchner S, Payne ME, Messer DF, Doty TJ, MacFall JR, Beyer JL, Krishnan KR.

Psychiatry Res. 2007 Jul 15;155(2):173-7. Epub 2007 May 23.

15.

The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task-switching.

Colzato LS, Waszak F, Nieuwenhuis S, Posthuma D, Hommel B.

Neuropsychologia. 2010 Jul;48(9):2764-8. doi: 10.1016/j.neuropsychologia.2010.04.023. Epub 2010 Apr 29.

PMID:
20434465
16.

The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease.

Rowe JB, Hughes L, Williams-Gray CH, Bishop S, Fallon S, Barker RA, Owen AM.

Neurobiol Aging. 2010 Jun;31(6):1064-8. doi: 10.1016/j.neurobiolaging.2008.07.009. Epub 2008 Aug 27.

17.

Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis.

Pelayo-Terán JM, Pérez-Iglesias R, Vázquez-Bourgon J, Mata I, Carrasco-Marín E, Vázquez-Barquero JL, Crespo-Facorro B.

Psychiatry Res. 2011 Jan 30;185(1-2):286-9. doi: 10.1016/j.psychres.2010.06.006. Epub 2010 Jun 29.

PMID:
20591499
18.

Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder.

Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S, Macciardi F, Deckert J, Kennedy JL.

Neuropsychopharmacology. 2006 Oct;31(10):2237-42. Epub 2006 Mar 8.

19.

COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia.

Bertolino A, Caforio G, Blasi G, Rampino A, Nardini M, Weinberger DR, Dallapiccola B, Sinibaldi L, Douzgou S.

Schizophr Res. 2007 Sep;95(1-3):253-5. Epub 2007 Jul 17. No abstract available.

PMID:
17644310
20.

Association study of catechol-O-methyltransferase (COMT) gene Val158Met polymorphism with auditory P300 in Chinese Han patients with schizophrenia.

Kang C, Xu X, Liu H, Yang J.

Psychiatry Res. 2010 Dec 30;180(2-3):153-5. doi: 10.1016/j.psychres.2008.07.008. Epub 2010 May 16.

PMID:
20483173

Supplemental Content

Support Center